Status:
UNKNOWN
Development and Validation of a Virtual Biopsy System in Kidney Transplant
Lead Sponsor:
Paris Translational Research Center for Organ Transplantation
Collaborating Sponsors:
Mayo Clinic
KU Leuven
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Currently, kidney allograft biopsies are routinely performed to determine diagnosis and prognosis of kidney allografts. The histological interpretation of these biopsies is based on the Banff consensu...
Detailed Description
In kidney transplantation, day-zero biopsies are essential to assess organ quality and discriminate the donor transmitted or acquired lesions and disease progression post-transplant. However, many cen...
Eligibility Criteria
Inclusion
- \- Kidney donors who underwent kidney biopsies performed prior to kidney transplantation, aged at least 18 years old.
Exclusion
- inadequate biopsies according to Banff international classification (number of glomeruli less than 10),
- biopsies with two or more Banff scores of interest missing.
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
12992 Patients enrolled
Trial Details
Trial ID
NCT04759209
Start Date
January 1 2000
End Date
December 31 2021
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Paris Transplant Group
Paris, France, 75015